Antibody testing will enhance the power and accuracy of COVID-19-prevention trials
- 1 June 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (6), 818-819
- https://doi.org/10.1038/s41591-020-0887-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Developing Covid-19 Vaccines at Pandemic SpeedNew England Journal of Medicine, 2020
- Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020Mmwr-Morbidity and Mortality Weekly Report, 2020
- Rational use of face masks in the COVID-19 pandemicThe Lancet Respiratory Medicine, 2020
- Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2Published by Cold Spring Harbor Laboratory ,2020
- Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic InfectionAmerican Journal of Epidemiology, 2018
- Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPTJAIDS Journal of Acquired Immune Deficiency Syndromes, 2017
- Randomized Controlled Trials With Time-to-Event Outcomes: How Much Does Prespecified Covariate Adjustment Increase Power?Annals of Epidemiology, 2006
- Effectiveness of Oseltamivir in Preventing Influenza in Household ContactsA Randomized Controlled TrialJama-Journal Of The American Medical Association, 2001
- A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.The American Journal of Tropical Medicine and Hygiene, 1999
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990